Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
Cheng DK, Jackevicius CA, Seidelin P, Feindel C, Rouleau JL. Can J Cardiol. 2004; 20(2):223-8.
Publications
Changes in prescribing patterns following publication of the ALLHAT trial
Austin PC, Mamdani MM, Tu K, Zwarenstein M. JAMA. 2004; 291(1):44-5.
Avoiding drug interactions in hospitalized patients
Juurlink D, Mamdani M, Iazzetta J, Etchells E. Healthc Q. 2004; 7(2):27-8.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(12):1359-66.
Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction
Ghali WA, Donaldson CR, Knudtson ML, Lewis SJ, Maxwell CJ, Tu JV. CMAJ. 2003; 169(1):35-7.
Should low-molecular-weight heparin be used in the treatment of acute coronary syndromes in rural hospitals?
Manuel DG, Knight CA, Mamdani M. Can J Rural Med. 2003; 8(3):173-8.
Association between ACE inhibitors and acute pancreatitis in the elderly
Cheng RM, Mamdani M, Jackevicius CA, Tu K. Ann Pharmacother. 2003; 37(7-8):994-8.
Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women’s Health Initiative study
Austin PC, Mamdani MM, Tu K, Jaakkimainen L. JAMA. 2003; 289(24):3241-2.
Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence
Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, Tran CT. BMJ. 2003; 326(7396):960-1.
Use of antidepressants among Canadian workers receiving depression-related short-term disability benefits
Dewa CS, Hoch JS, Goering P, Lin E, Paterson M. Psychiatr Serv. 2003; 54(5):724-9.